Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
About This Series
The seriousness of meningitis cannot be overstated. Once it starts to develop, meningococcal disease progresses rapidly and even patients who receive treatment in time are at risk for life-long disabilities. Fortunately, the vast majority of cases of meningitis due to meningococcal infection are preventable through vaccines. In this 4-part series, internationally recognized experts will explore the epidemiology, burden, and prevention of meningococcal disease.
The seriousness of meningitis cannot be overstated. Once it starts to develop, meningococcal disease progresses rapidly and even patients who receive treatment in time are at risk for life-long disabilities. Fortunately, the vast majority of cases of meningitis due to meningococcal infection are preventable through vaccines. In this 4-part series, internationally recognized experts will explore the epidemiology, burden, and prevention of meningococcal disease.
Host
Kevan H. Chambers, CBiol, MRSB
MEDEGY Science & Healthcare Co.
St. Petersburg, Florida, United States
Faculty
Muhamed-Kheir Taha, MD, PhD
Head, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci
Associate Professor
Institute Pasteur
Paris, France
George Kassianos, MD (Hons)
General Practitioner
National Immunization Lead
Royal College of General Practitioners
President
British Global and Travel Health Association
London, United Kingdom
